返回 
加入收藏
咳喘药学服务门诊工作模式构建与效果分析
x
请在关注微信后，向客服人员索取文件
| 篇名： | 咳喘药学服务门诊工作模式构建与效果分析 |
| TITLE： | Construction and effectiveness analysis of working model of cough and asthma pharmaceutical care clinic |
| 摘要： | 目的 建立咳喘药学服务门诊工作模式，分析门诊药学服务干预对患者产生的效果。方法我院开设咳喘药学服务门诊，建立完善的规章制度，配置完整的软硬件设施，并确定药学服务流程。收集2021年5月－2024年12月就诊患者的基本信息，包括性别、年龄、居住地和病程等；收集患者就诊和随访时的健康状况、疾病严重程度、吸入剂使用技术和用药依从性等指标，并进行统计分析，以考察药学服务干预对患者的影响。结果确立了我院咳喘药学服务门诊服务流程，共收集了215例患者的基本信息。就诊患者中男性占比为55.35%、平均年龄为（60.91±15.75）岁，60～69岁患者占比最大（28.37%），用药依从性较差[平均得分为（5.64±1.76）分]；诊断为慢性阻塞性肺疾病、使用布地奈德福莫特罗粉吸入剂的患者占比最多。68例随访患者中，欧洲五维健康量表评分上升5.81分（P＜0.05），慢性阻塞性肺疾病评估测试评分下降4.05分（P＜0.05），疾病影响程度减小；哮喘控制测试评分上升4.80分，达到部分控制水平。吸入剂使用技术评分升高2.31分（P＜0.05），用药依从性评分升高1.09分（P＜0.05），患者满意度超过90%。结论经过药学服务干预后，患者的健康状况、疾病严重程度、吸入剂使用技术和用药依从性均有所改善，对咳喘药学服务门诊满意度较高。咳喘药学服务门诊提供的药学服务干预能改善患者的疾病症状和用药依从性，提高医院合理用药水平。 |
| ABSTRACT： | OBJECTIVE To establish a working model for the cough and asthma pharmaceutical care clinic and analyze the effects of outpatient pharmaceutical care interventions on patients. METHODS A pharmaceutical care clinic for cough and asthma was established in our hospital， with comprehensive regulations and rules， complete infrastructure and defined pharmaceutical care workflows. The demographic data of patients （gender， age， residence， disease duration and so on） were collected from May 2021 to December 2024. Indicators including health status， disease severity， inhalation technique， and medication adherence during visits and follow-up were collected and analyzed statistically， to assess the effects of pharmaceutical care interventions on patients. RESULTS The service procedure for the cough and asthma pharmaceutical care clinic in our hospital was established. A total of 215 patients’ basic information was collected. It was found that among the patients， males accounted for 55.35%， with an average age of （60.91±15.75） years old. Patients aged 60 to 69 constituted the largest proportion at 28.37%， and they exhibited relatively poor medication adherence [with an average score of （5.64±1.76）]. The majority of patients were diagnosed with chronic obstructive pulmonary disease （COPD） and prescribed budesonide/formoterol powder inhalers. In 68 follow-up cases， EQ-5D-5L scores increased by 5.81 points （P＜0.05）； COPD Assessment Test （CAT） scores decreased by 4.05 points （P＜0.05）， indicating reduced disease burden. Asthma Control Test （ACT） scores improved by 4.80 points， reaching partial control levels. Inhaler technique scores increased by 2.31 points （P＜0.05）. Medication adherence scores rose by 1.09 points （P＜0.05）. Patient satisfaction was over 90%. CONCLUSIONS After pharmaceutical care intervention， patients’ health status， disease severity， inhalant use technique， and compliance have all improved， and their satisfaction with the cough and asthma pharmaceutical care outpatient service is high. The pharmaceutical care intervention provided by the cough and asthma pharmaceutical care outpatient service can improve patients’ disease symptoms and medication compliance， and enhance the level of safe and rational drug use in the hospital. |
| 期刊： | 2025年第36卷第15期 |
| 作者： | 李翔；李颖；汪永忠；夏伦祝 |
| AUTHORS： | LI Xiang，LI Ying，WANG Yongzhong，XIA Lunzhu |
| 关键字： | 咳喘；药学门诊；慢性阻塞性肺疾病；哮喘；药学服务 |
| KEYWORDS： | cough and asthma； pharmaceutical clinic； chronic obstructive pulmonary disease； asthma； pharmaceutical care |
| 阅读数： | 8 次 |
| 本月下载数： | 2 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
